This course has expired. View available courses.
Endocrinology
Injectable Therapy in the Vulnerable Older Adult (CSEM)
The COVID-19 pandemic has created significant challenges for people living with diabetes. Some patients have thrived with the increased emphasis of self-management, where other vulnerable populations have struggled with a decrease in support in maintaining glycemic control and optimizing management. This patient case will review the clinical considerations of a vulnerable older adult with type 2 diabetes who is currently using insulin.
DURATION
30 min
PROFESSION
Physician, Nursing, Specialist
# OF CREDITS
0.5
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2023-05-31
The COVID-19 pandemic has created significant challenges for people living with diabetes. Some patients have thrived with the increased emphasis of self-management, where other vulnerable populations have struggled with a decrease in support in maintaining glycemic control and optimizing management. This patient case will review the clinical considerations of a vulnerable older adult with type 2 diabetes who is currently using insulin.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
Kim Connelly, MBBS, PhD, FSCMR, FCCS
Céline Huot, MD, FRCPC
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Determine the management of hyperglycemia in an older adult with type 2 diabetes currently using basal insulin
- Discuss the role of frailty and cognitive impairment on diabetes management
- Review the role of the diabetes management team and interprofessional collaboration to improve outcomes in older adults with type 2 diabetes